EBF1 and COVID-19: In all, 8 out of 107 HSC/MPP cells in HC and 2 out of 77 HSC/MPP cells in COVID-19 patients with mild disease expressed ID3, but not in severe cases, although PAX5 and EBF1 were not identified (Fig. 4a).